CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has announced it will release its Second Quarter Fiscal 2025 financial results ...

“Alto helps our partners elevate the patient experience, improve medication access and set new standards for convenience, ...

Cencora COR +0.57% Get Free Report has outperformed the market over the past 10 years by 7.55% on an annualized basis ...

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York ...

Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 8.3% over the past month. The stock hit a new 52-week high of $271.86 in the previous session.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several ...

Cencora Inc., a Conshohocken-based wholesale drug distributor, scrubbed a diversity, equity, and inclusion page from its website. Its chief DEI officer no longer works there, according to her ...

Cencora COR has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table below ...

Argus analyst David Toung raised the firm’s price target on Cencora (COR) to $280 from $270 and keeps a Buy rating on the shares. The company delivered strong results for Q1 and expects topline ...